Q96MU7 (YTDC1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 96.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: YTH domain-containing protein 1 Alternative name(s): Putative splicing factor YT521 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 727 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May be part of a signal transduction pathway that influences splice site selection By similarity. |
| Subunit structure | Interacts with EMD, KHDRBS1/SAM68, KHDRBS3, TRA2B/SFRS10, SC35 and SF2 By similarity. Interacts with RBMX. Ref.5 Ref.16 |
| Subcellular location | Nucleus By similarity. Note: Localizes to a novel subnuclear structure, the YT bodies By similarity. |
| Sequence similarities | Contains 1 YTH domain. |
| Sequence caution | The sequence AAY41024.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence BAB71181.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Biological process | mRNA processing mRNA splicing |
| Cellular component | Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Molecular function | protein binding Inferred from physical interaction Ref.16. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q96MU7-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q96MU7-2) The sequence of this isoform differs from the canonical sequence as follows: 325-342: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 727 | 727 | YTH domain-containing protein 1 | PRO_0000223076 | |||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||
| Domain | 355 – 492 | 138 | YTH | ||||||||||||||||||||||||||||||||||||
| Compositional bias | 172 – 260 | 89 | Glu-rich | ||||||||||||||||||||||||||||||||||||
| Compositional bias | 508 – 581 | 74 | Arg-rich | ||||||||||||||||||||||||||||||||||||
| Compositional bias | 601 – 643 | 43 | Pro-rich | ||||||||||||||||||||||||||||||||||||
| Compositional bias | 647 – 727 | 81 | Arg-rich | ||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 118 | 1 | Phosphoserine Ref.12 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 146 | 1 | Phosphoserine Ref.6 Ref.7 Ref.8 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 148 | 1 | Phosphothreonine Ref.6 Ref.7 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 275 | 1 | Phosphoserine Ref.6 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 308 | 1 | Phosphoserine Ref.6 Ref.8 Ref.9 Ref.10 Ref.12 Ref.13 Ref.14 Ref.15 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 315 | 1 | Phosphoserine Ref.8 Ref.14 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 317 | 1 | Phosphoserine Ref.8 Ref.14 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 318 | 1 | Phosphoserine Ref.8 Ref.14 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 320 | 1 | Phosphoserine Ref.6 Ref.8 Ref.14 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 322 | 1 | Phosphoserine Ref.8 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 323 | 1 | Phosphotyrosine Ref.8 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 326 | 1 | Phosphoserine Ref.6 Ref.8 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 424 | 1 | Phosphoserine Ref.14 Ref.15 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 515 | 1 | Phosphoserine Ref.8 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 545 | 1 | Phosphoserine Ref.11 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 577 | 1 | Phosphoserine Ref.12 | ||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 325 – 342 | 18 | Missing in isoform 2. | VSP_006818 | |||||||||||||||||||||||||||||||||||
| Natural variant | 183 | 1 | H → R. Corresponds to variant rs3813832 [ dbSNP | Ensembl ]. | VAR_053746 | |||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 619 | 1 | H → Q in BAB71181. Ref.1 | ||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||
| Helix | 346 – 351 | 6 | |||||||||||||||||||||||||||||||||||||
| Turn | 352 – 354 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 356 – 363 | 8 | |||||||||||||||||||||||||||||||||||||
| Helix | 365 – 374 | 10 | |||||||||||||||||||||||||||||||||||||
| Helix | 381 – 393 | 13 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 397 – 403 | 7 | |||||||||||||||||||||||||||||||||||||
| Turn | 404 – 406 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 407 – 420 | 14 | |||||||||||||||||||||||||||||||||||||
| Helix | 436 – 439 | 4 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 441 – 449 | 9 | |||||||||||||||||||||||||||||||||||||
| Helix | 455 – 458 | 4 | |||||||||||||||||||||||||||||||||||||
| Turn | 464 – 466 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 467 – 469 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 478 – 480 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 482 – 491 | 10 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 496 – 498 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 501 – 508 | 8 | |||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [2] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed: 15815621] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Skin. |
| [4] | "Prediction of the coding sequences of unidentified human genes. XXII. The complete sequences of 50 new cDNA clones which code for large proteins." Nagase T., Kikuno R., Ohara O. DNA Res. 8:319-327(2001) [PubMed: 11853319] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 248-727 (ISOFORM 1). Tissue: Brain. |
| [5] | "Emerin interacts in vitro with the splicing-associated factor, YT521-B." Wilkinson F.L., Holaska J.M., Zhang Z., Sharma A., Manilal S., Holt I., Stamm S., Wilson K.L., Morris G.E. Eur. J. Biochem. 270:2459-2466(2003) [PubMed: 12755701] [Abstract] Cited for: INTERACTION WITH EMD. |
| [6] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; THR-148; SER-275; SER-308; SER-320 AND SER-326, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [7] | "Global phosphoproteome of HT-29 human colon adenocarcinoma cells." Kim J.-E., Tannenbaum S.R., White F.M. J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146 AND THR-148, MASS SPECTROMETRY. Tissue: Colon adenocarcinoma. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; SER-308; SER-315; SER-317; SER-318; SER-320; SER-322; TYR-323; SER-326 AND SER-515, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Phosphoproteome analysis of the human mitotic spindle." Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R. Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006) [PubMed: 16565220] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308, MASS SPECTROMETRY. Tissue: Cervix adenocarcinoma. |
| [11] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-545, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis." Wang B., Malik R., Nigg E.A., Korner R. Anal. Chem. 80:9526-9533(2008) [PubMed: 19007248] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118; SER-308 AND SER-577, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308; SER-315; SER-317; SER-318; SER-320 AND SER-424, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308 AND SER-424, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [16] | "Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A/C)-rich regions in pre-mRNA." Heinrich B., Zhang Z., Raitskin O., Hiller M., Benderska N., Hartmann A.M., Bracco L., Elliott D., Ben-Ari S., Soreq H., Sperling J., Sperling R., Stamm S. J. Biol. Chem. 284:14303-14315(2009) [PubMed: 19282290] [Abstract] Cited for: INTERACTION WITH RBMX. |
| [17] | "Solution structure of the YTH domain in YTH domain-containing protein 1 (putative splicing factor yt521)." RIKEN structural genomics initiative (RSGI) Submitted (OCT-2007) to the PDB data bank Cited for: STRUCTURE BY NMR OF 334-509. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AK056430 mRNA. Translation: BAB71181.1. Different initiation. AC074378 Genomic DNA. Translation: AAY41024.1. Sequence problems. BC041119 mRNA. Translation: AAH41119.1. BC053863 mRNA. Translation: AAH53863.1. AB075846 mRNA. Translation: BAB85552.1. | ||||||||||||
| IPI | IPI00144293. IPI00376222. | ||||||||||||
| RefSeq | NP_001026902.1. NM_001031732.2. NP_588611.2. NM_133370.2. | ||||||||||||
| UniGene | Hs.175955. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q96MU7. | ||||||||||||
| SMR | Q96MU7. Positions 334-509. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q96MU7. 18 interactions. | ||||||||||||
| STRING | Q96MU7. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q96MU7. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 47606762. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q96MU7. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000344157; ENSP00000339245; ENSG00000083896. | ||||||||||||
| GeneID | 91746. | ||||||||||||
| KEGG | hsa:91746. | ||||||||||||
| UCSC | uc003hdx.1. human. uc003hdy.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 91746. | ||||||||||||
| GeneCards | GC04M069176. | ||||||||||||
| HGNC | HGNC:30626. YTHDC1. | ||||||||||||
| HPA | HPA036462. HPA036463. | ||||||||||||
| neXtProt | NX_Q96MU7. | ||||||||||||
| PharmGKB | PA143485673. | ||||||||||||
| HUGE | Search... | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | prNOG15717. | ||||||||||||
| GeneTree | ENSGT00570000079050. | ||||||||||||
| HOGENOM | HBG715473. | ||||||||||||
| HOVERGEN | HBG055528. | ||||||||||||
| InParanoid | Q96MU7. | ||||||||||||
| OMA | RKSDRME. | ||||||||||||
| OrthoDB | EOG4ZW5BC. | ||||||||||||
| PhylomeDB | Q96MU7. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q96MU7. | ||||||||||||
| Bgee | Q96MU7. | ||||||||||||
| CleanEx | HS_YTHDC1. | ||||||||||||
| Genevestigator | Q96MU7. | ||||||||||||
| GermOnline | ENSG00000083896. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR007275. YTH_domain. [Graphical view] | ||||||||||||
| Pfam | PF04146. YTH. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS50882. YTH. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| NextBio | 77419. | ||||||||||||
Entry information
| Entry name | YTDC1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96MU7 Secondary accession number(s): Q4W5Q3, Q7Z622, Q8TF35 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 4 Human chromosome 4: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with